Reblozyl

UNIISPLATC B03XA06

Last synced from FDA National Drug Code directory (United States) on June 3, 2026

Identification

ManufacturerCelgene Corporation

CountryUS (United States)

ATC codeB03XA06

Dispensing—

ReimbursedNo

SourceFDA National Drug Code directory (United States)

Last synced6/3/2026

Packs · 1

ndc11
5957277501
1 VIAL, GLASS in 1 CARTON (59572-775-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS

Annotations

UNII (FDA Substance ID)

AQK7UBA1LS

LUSPATERCEPT

RxCUI 2262544

DailyMed SPL labels

1 version tracked

Raw payload (JSON)

{
  "unii": {
    "unii": "AQK7UBA1LS",
    "rxcui": "2262544",
    "inchikey": null,
    "display_name": "LUSPATERCEPT",
    "substance_type": "protein",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "SUBCUTANEOUS",
  "spl_meta": {
    "82f4d266-3f52-41eb-86ba-0abf3cf468e8": {
      "match": "brand_token",
      "title": "REBLOZYL (LUSPATERCEPT) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CELGENE CORPORATION]",
      "spl_version": "20",
      "published_date": "2026-03-12"
    }
  },
  "productid": "59572-775_769ec39a-61bd-4726-b14a-9594897baa67",
  "productndc": "59572-775",
  "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "LUSPATERCEPT",
  "proprietary_name": "Reblozyl",
  "active_ingred_unit": "mg/1",
  "application_number": "BLA761136",
  "marketing_category": "BLA",
  "nonproprietary_name": "Luspatercept",
  "start_marketing_date": "20191108",
  "active_numerator_strength": "75"
}

Related drugs

Other records sharing ATC code B03XA06.

Access this data programmatically

Query Reblozyl and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.

Get a free API key Read the API docs